• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH对酮康唑片崩解和溶出的影响。

Effect of pH on disintegration and dissolution of ketoconazole tablets.

作者信息

Carlson J A, Mann H J, Canafax D M

出版信息

Am J Hosp Pharm. 1983 Aug;40(8):1334-6.

PMID:6310994
Abstract

The effect of pH on the in vitro disintegration, dissolution, and solubility of ketoconazole tablets was studied. One 200-mg ketoconazole tablet was added to each of five different buffer solutions having pH values of 2 to 6;900 ml of each solution containing the ketoconazole was placed in a stationary basket dissolution device and stirred at 500 rpm at 37 degrees C for 60 minutes. Single 1-ml samples of each solution were obtained at 1,3, and 5 minutes after addition of the drug, and then every 5 minutes for the duration of the sampling period. This same procedure was repeated using two 200-mg tablets in the buffer solution at pH 3. The effect of pH on ketoconazole solubility was studied by gradually increasing the pH of a ketoconazole solution at pH 3 to pH 10. Samples of this solution were analyzed periodically after allowing a short period for equilibration of pH. All samples were assayed spectrophotometrically against blanks, and concentrations were determined by comparison with a standard curve. Disintegration of ketoconazole tablets occurred within 5 minutes in each buffer solution and was unaffected by pH. At pH 2 and 3, dissolution of ketoconazole was greater than 85% complete after five minutes, and all ketoconazole had dissolved after 30 minutes. As pH increased, the rate and extent of dissolution slowed; only 10% of ketoconazole was dissolved after 60 minutes at pH 6. Ketoconazole precipitated rapidly from solution as the pH of the dissolution medium exceeded 5.5. There was no difference in the rate or extent of dissolution of ketoconazole for the two doses studied at pH 3. In the buffer solutions tested, dissolution but not disintegration of ketoconazole tablets is pH-dependent. Dissolution characteristics of 200- and 400-mg doses of ketoconazole are similar at pH 3.

摘要

研究了pH值对酮康唑片体外崩解、溶出和溶解度的影响。将1片200毫克的酮康唑片分别加入到5种pH值为2至6的不同缓冲溶液中;将900毫升含有酮康唑的每种溶液置于固定篮式溶出装置中,在37℃下以500转/分钟搅拌60分钟。在加入药物后1、3和5分钟时,从每种溶液中取1毫升单一样品,然后在采样期内每隔5分钟取样一次。在pH值为3的缓冲溶液中使用2片200毫克的片剂重复相同的程序。通过将pH值为3的酮康唑溶液的pH值逐渐提高到10来研究pH值对酮康唑溶解度的影响。在允许pH值短暂平衡后,定期分析该溶液的样品。所有样品均与空白对照进行分光光度测定,并通过与标准曲线比较来确定浓度。酮康唑片在每种缓冲溶液中5分钟内发生崩解,且不受pH值影响。在pH值为2和3时,5分钟后酮康唑的溶出度超过85%,30分钟后所有酮康唑均已溶解。随着pH值升高,溶出速率和程度减慢;在pH值为6时,60分钟后只有10%的酮康唑溶解。当溶出介质的pH值超过5.5时,酮康唑迅速从溶液中沉淀出来。在pH值为3时,所研究的两种剂量的酮康唑的溶出速率或程度没有差异。在所测试的缓冲溶液中,酮康唑片的溶出而非崩解依赖于pH值。在pH值为3时,200毫克和400毫克剂量的酮康唑的溶出特性相似。

相似文献

1
Effect of pH on disintegration and dissolution of ketoconazole tablets.pH对酮康唑片崩解和溶出的影响。
Am J Hosp Pharm. 1983 Aug;40(8):1334-6.
2
A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.用于回肠-结肠给药的pH响应性聚合物药物释放性能的体外比较评估。
Int J Pharm. 2006 Feb 3;308(1-2):52-60. doi: 10.1016/j.ijpharm.2005.10.038. Epub 2005 Dec 13.
3
The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.地西泮普通片剂在人体中的生物利用度——第一部分:与片剂溶出速率的相关性
Int J Clin Pharmacol Ther Toxicol. 1982 Apr;20(4):159-65.
4
Lot-to-lot variation in dissolution of tolbutamide tablets.甲苯磺丁脲片溶出度的批次间差异。
Am J Hosp Pharm. 1980 Oct;37(10):1329-32.
5
Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.溶出介质pH值和美国药典1篮法转速对速释型盐酸二甲双胍片的溶蚀和崩解特性的影响
Pharm Dev Technol. 2015;20(5):540-5. doi: 10.3109/10837450.2014.892132. Epub 2014 Mar 12.
6
Stability of nitroglycerin tablets submitted by U.S. hospitals.美国医院提交的硝酸甘油片的稳定性。
Am J Hosp Pharm. 1983 Dec;40(12):2170-5.
7
Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation.基于生物利用度评价的尼莫地平片溶出介质的开发
Eur J Pharm Sci. 2004 Mar;21(4):487-91. doi: 10.1016/j.ejps.2003.11.009.
8
PH-dependent drug release from certain commercial tablets.
Am J Hosp Pharm. 1977 Dec;34(12):1323-6.
9
Consumer vinegar test for determining calcium disintegration.用于测定钙崩解度的食用醋测试
Am J Hosp Pharm. 1992 Sep;49(9):2218-22.
10
A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and 'in vivo' evaluation.一种用于阴道给药的新型酮康唑生物粘附泡腾片:设计、体外及体内评价
Int J Pharm. 2008 Feb 28;350(1-2):181-7. doi: 10.1016/j.ijpharm.2007.08.042. Epub 2007 Aug 31.

引用本文的文献

1
Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach.采用质量源于设计(QbD)方法的氯诺昔康分散片的设计与优化
Pharmaceuticals (Basel). 2022 Nov 25;15(12):1463. doi: 10.3390/ph15121463.
2
Improved Subcutaneous Delivery of Ketoconazole Using EpiDerm and HSPiP Software-Based Simulations as Assessed by Cell Viability, Cellular Uptake, Permeation, and Hemolysis Studies.使用EpiDerm和基于HSPiP软件的模拟方法改进酮康唑的皮下给药,通过细胞活力、细胞摄取、渗透和溶血研究进行评估。
ACS Omega. 2022 Nov 9;7(46):42593-42606. doi: 10.1021/acsomega.2c06001. eCollection 2022 Nov 22.
3
Impact of Composition and Morphology of Ketoconazole-Loaded Solid Lipid Nanoparticles on Intestinal Permeation and Gastroplus-Based Prediction Studies.
酮康唑负载型固体脂质纳米粒的组成和形态对肠道渗透的影响及基于Gastroplus的预测研究
ACS Omega. 2022 Jun 20;7(26):22406-22420. doi: 10.1021/acsomega.2c01272. eCollection 2022 Jul 5.
4
The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles.三唑类药物的药代动力学和药效学相互作用概述
Pharmaceutics. 2021 Nov 19;13(11):1961. doi: 10.3390/pharmaceutics13111961.
5
Clinically significant drug interactions with antacids: an update.与抗酸剂有临床意义的药物相互作用:更新。
Drugs. 2011 Oct 1;71(14):1839-64. doi: 10.2165/11593990-000000000-00000.
6
In vitro-in vivo correlation: perspectives on model development.体外-体内相关性:模型开发的视角。
Int J Pharm. 2011 Oct 10;418(1):142-8. doi: 10.1016/j.ijpharm.2011.01.010. Epub 2011 Jan 13.
7
Drug-drug interaction profiles of proton pump inhibitors.质子泵抑制剂的药物相互作用谱。
Clin Pharmacokinet. 2010 Aug;49(8):509-33. doi: 10.2165/11531320-000000000-00000.
8
Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.胃肠道模拟在高渗透性化合物生物豁免扩展中的应用。
AAPS J. 2008;10(1):213-26. doi: 10.1208/s12248-008-9023-x. Epub 2008 Apr 2.
9
Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo pH system.使用Bravo pH系统测定禁食和进食的清醒食蟹猴的胃内pH值和胃停留时间。
Pharm Res. 2008 Jan;25(1):123-34. doi: 10.1007/s11095-007-9358-5. Epub 2007 Jul 6.
10
Pharmacokinetic drug interaction profiles of proton pump inhibitors.质子泵抑制剂的药代动力学药物相互作用概况。
Drug Saf. 2006;29(9):769-84. doi: 10.2165/00002018-200629090-00002.